Air Quality Guidelines Global Update 2005 - World Health ...

DETERMINANTS OF SUSCEPTIBILITY
3. Utell MJ, Frampton MW. Who is susceptible to particulate matter and why?
Inhalation Toxicology, 2000, 12(Suppl. 1):37–40.
4. Last JM. A dictionary of epidemiology, 4th ed. New York, Oxford University
Press, 2000.
5. Cohen AJ et al. Mortality impacts of urban air pollution. In: Ezzati M et al.,
eds. Comparative quantification of health risks: global and regional burden
of disease attributable to selected major risk factors. Geneva, World Health
Organization, 2004.
6. Riediker M et al. Particulate matter exposure in cars is associated with
cardiovascular effects in healthy, young men. American Journal of
Respiratory and Critical Care Medicine, 2004, 169:934–940.
7. Kleeberger SR. Genetic aspects of susceptibility to air pollution. European
Respiratory Journal, 2003, 40(Suppl.):52s–56s.
8. Utell MJ, Frampton MW. Toxicologic methods: controlled human
exposures. Environmental Health Perspectives, 2000, 108(Suppl. 4): 605–613
9. Frampton MW et al. Human clinical studies of airborne pollutants. In:
Gardner DE, ed. Toxicology of the lung, 4th ed. London, Taylor & Francis,
2006.
10. Zanobetti A, Schwartz J. Are diabetics more susceptible to the health effects
of airborne particles? American Journal of Respiratory and Critical Care
Medicine, 2001, 164:831–833.
11. Brimblecombe P. The big smoke: a history of air pollution in London since
medieval times. London, Methuen, 1987.
12. Utell MJ, Frampton MW. Sulfur dioxide and sulfuric acid aerosols. In: Rom
WM, ed. Environmental and occupational medicine. Boston, MA, Little,
Brown & Co., 1998.
13. Allred EN et al. Short-term effects of carbon monoxide exposure on the
exercise performance of subjects with coronary artery disease. New England
Journal of Medicine, 1989, 321:1426–1432.
14. Torres A et al. Airway inflammation in smokers and nonsmokers with
varying responsiveness to ozone. American Journal of Respiratory and
Critical Care Medicine, 1997, 156:728–736.
15. Daigle CC et al. Ultrafine particle deposition in humans during rest and
exercise. Inhalation Toxicology, 2003, 15:539–552.
16. Kim CS, Kang TC. Comparative measurement of lung deposition of inhaled
fine particles in normal subjects and patients with obstructive airway
disease. American Journal of Respiratory and Critical Care Medicine, 1997,
155:899–905.
17. Svartengren M et al. Regional deposition of 3.6-μm particles and lung
function in asthmatic subjects. Journal of Applied Physiology, 1991,
71:2238–2243.
127